Literature DB >> 23137214

Preliminary evaluation for cancer chemopreventive and cytotoxic potential of naturally growing ethnobotanically selected plants of Pakistan.

Bushra Mirza, Tamara P Kondratyuk, Eun-Jung Park, Brittany E Burns, Laura E Marler, John M Pezzuto.   

Abstract

CONTEXT: Natural products are a very productive source of leads for the development of medicines. Six Pakistani plants were chosen for study based on ethnobotanical data.
OBJECTIVE: Exploration of important medicinal plants of Pakistan for cancer treatment.
MATERIALS AND METHODS: The crude extracts of the six plants and their fractions were tested for inhibition of nuclear factor κB (NFκB), aromatase, and nitric oxide (NO) production in lipopolysaccharide (LPS)-activated murine macrophage RAW 264.7 cells, induction of quinone reductase 1 (QR1), agonism of retinoid X receptor, and growth inhibition with MCF-7, LU-1 and MDA-MB-231 cancer cells.
RESULTS: Two samples of Withania coagulans (Stocks) Dunal (Solanaceae) demonstrated inhibition of TNF-α induced activity of NFκB with IC₅₀ values of 2.6 and 4.3 µg/mL, respectively. Two fractions from W. coagulans and Euphorbia wallichii Hook F. (Euphorbiaceae) aerial parts inhibited aromatase with IC₅₀ values of 17.0 and 17.7 µg/mL, respectively. A total of 13 samples (five from E. wallichii, one from Acer oblongifolium Hort. ex Dippel (Aceraceae), one from Aster thomsonii C. B. Clarke (Asteraceae) and six from W. coagulans aerial parts with fruits) inhibited NO production with IC₅₀ values ranging from 1.3 to 15.6 µg/mL. Fourteen samples demonstrated induction of QR1 with CD ranging from 1.0 to 20.6 µg/mL, and a total of eight extracts and fractions inhibited the proliferation of cancer cells in culture with IC₅₀ values ranging from 1.2 to 7.8 µg/mL. DISCUSSION AND
CONCLUSION: Selected plants can be a valuable source of chemopreventive and anticancer products. W. coagulans aerial parts showed the strongest activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23137214     DOI: 10.3109/13880209.2012.728612

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  6 in total

1.  Biological Evaluation of Endophytic Fungus Chaetomium sp. NF15 of Justicia adhatoda L.: A Potential Candidate for Drug Discovery.

Authors:  Nighat Fatima; Usman Mukhtar; Muneer Ahmed Qazi; Muniba Jadoon; Safia Ahmed
Journal:  Jundishapur J Microbiol       Date:  2016-06-05       Impact factor: 0.747

2.  A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha ( Withania somnifera) in Aging, Overweight Males.

Authors:  Adrian L Lopresti; Peter D Drummond; Stephen J Smith
Journal:  Am J Mens Health       Date:  2019 Mar-Apr

3.  Isolation of bioactive compounds from Bergenia ciliata (haw.) Sternb rhizome and their antioxidant and anticholinesterase activities.

Authors:  Roheena Zafar; Habib Ullah; Muhammad Zahoor; Abdul Sadiq
Journal:  BMC Complement Altern Med       Date:  2019-11-06       Impact factor: 3.659

4.  Investigation of Chemopreventive and Antiproliferative Potential of Dicliptera roxburghiana.

Authors:  Bushra Ahmad; Muhammad Rashid Khan; Naseer Ali Shah; Tamara P Kondratyuk; Nadeem Ahmed; John M Pezzuto; Asma Gul; Aishma Khattak
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.279

Review 5.  Cancer and apoptosis: The apoptotic activity of plant and marine natural products and their potential as targeted cancer therapeutics.

Authors:  Gul-E-Saba Chaudhry; Abdah Md Akim; Yeong Yik Sung; Tengku Muhammad Tengku Sifzizul
Journal:  Front Pharmacol       Date:  2022-08-10       Impact factor: 5.988

Review 6.  Hidden in Plants-A Review of the Anticancer Potential of the Solanaceae Family in In Vitro and In Vivo Studies.

Authors:  Tomasz Kowalczyk; Anna Merecz-Sadowska; Patricia Rijo; Mattia Mori; Sophia Hatziantoniou; Karol Górski; Janusz Szemraj; Janusz Piekarski; Tomasz Śliwiński; Michał Bijak; Przemysław Sitarek
Journal:  Cancers (Basel)       Date:  2022-03-11       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.